G. Baciarello

A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

Karim Fizazi, Aline Maillard, Nicolas Penel et al. · Annals of Oncology · 2019 · 240 citations · Full text

Malignant Disease, Medicine, Phase Iii Trial +8

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

A. Krämer, Tilmann Bochtler, Chantal Pauli et al. · Annals of Oncology · 2022 · 173 citations · Full text

Esophageal Cancer, Unknown Primary, Medicine +6

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL

Julie N. Graff, G. Baciarello, Andrew J. Armstrong et al. · Annals of Oncology · 2015 · 115 citations · Full text

Urology, Oncology, Medicine +5

Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre

Fiorella Ruatta, Lisa Derosa, Bernard Escudier et al. · European Journal of Cancer · 2018 · 90 citations

Large Cancer Centre, Urology, Surgical Oncology +9

Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I–II)

Maria Sofia Rosati, Cristina Raimondi, G. Baciarello et al. · Annals of Oncology · 2010 · 22 citations

Breast Oncology, Medicine, Pharmacology +10